2 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Thymoma: new trials by email Literature Review of Thymoma trials Research Report on Thymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors Cyclophosphamide, Doxorubicin, and Cisplatin (CAP), nab-Paclitaxel and Carboplatin - Thymoma and Thymic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 116 | 2026-03-01 | 2026-03-11 |
| Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) Chemotherapy, Radiotherapy - Thymic Carcinoma | Phase 3 | Recruiting | Fudan University | 172 | 2024-04-09 | 2026-04-27 |
| Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma Cisplatin, Etoposide, radiotherapy - Thymoma and Thymic Carcinoma | Phase 3 | Withdrawn | Fudan University | 2023-12-01 | 2026-04-27 | |
| Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma radiotherapy - Thymoma | Phase 3 | Unknown | Chinese Academy of Medical Sciences | 210 | 2013-07-01 | 2020-07-16 |
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy thymectomy plus prednisone, prednisone alone - Myasthenia Gravis | Phase 3 | Completed | University of Alabama at Birmingham | 126 | 2006-06-01 | 2017-05-23 |
Adrenocortical Carcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Astrocytoma (1) · Bile Duct Neoplasms (1) · Blast Crisis (1) · Brain Neoplasms (1) · Breast Carcinoma In Situ (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Islet Cell (1) · Carcinoma, Non-Small-Cell Lung (1)
Hemic and Lymphatic Diseases (6) · Lymphatic Diseases (6) · Neoplasms by Histologic Type (6) · Neoplasms by Site (6) · Neoplasms, Complex and Mixed (6) · Thoracic Neoplasms (6) · Thymus Neoplasms (6) · Neoplasms (5) · Immune System Diseases (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Respiratory Tract Diseases (2) · Adenocarcinoma (1) · Adenoma (1) · Adenoma, Islet Cell (1)
Radiotherapy (3) · Cisplatin (2) · 130-nm albumin-bound paclitaxel (1) · Carboplatin (1) · Cyclophosphamide (1) · Doxorubicin (1) · Drug Therapy (1) · Etoposide (1) · Fentanyl (1) · Prednisolone (1) · Prednisone (1) · Thymectomy (1)
Fudan University (2) · Chinese Academy of Medical Sciences (1) · INSYS Therapeutics Inc (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · University of Alabama at Birmingham (1)
China (4) · United States (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · Chile (1) · Germany (1) · Italy (1) · Japan (1) · Mexico (1) · Netherlands (1) · Poland (1) · Portugal (1) · South Africa (1)
Fan Jiang, MD, PhD (1) · Gary Cutter, PhD (1) · Gil Wolfe, MD (1) · Henry Kaminski, MD (1) · Kailiang Wu, MD. PhD (1) · Larry Dillaha, MD (1) · Qinfu Feng, M.D. (1)
PMID 18567886, PMID 18675464, PMID 22047648, PMID 22480131, PMID 23278584, PMID 27020837, PMID 27509100, PMID 30692052, PMID 32611638
U01NS042685 (1)